

DOS Kongressen 2017 ·
61
Hip fracture, comorbidity, and the risk of myocardi-
al infarction and stroke: A Danish nationwide cohort
study, 1995-2015
Alma B Pedersen , Vera Ehrenstein, Szimonetta K. Szépligeti, Henrik T Sørensen
Department of Clinical Epidemiology, Aarhus Universityhospital;
Background:
Hip fracture is a common trauma, associated with high morbidity
and mortality.
Purpose / Aim of Study:
We evaluated risks of MI and stroke in hip fracture
patients compared with general population. We also examined the interaction
between hip fracture and comorbidity with respect to risks of MI or stroke,
defined as excess of risk explained by combining risks of hip fracture and co-
morbidity.
Materials and Methods:
A population-based cohort study using Danish
health registries from 1995-2015 including 110,563 hip fracture patients
and 552,774 members of the 2015 including 110,563 hip fracture patients
and 552,774 members of the comparison cohort from the general population.
comparison cohort from the general population.
Findings / Results:
Thirty-day cumulative incidences of MI were 1.15% among
patients with hip fracture and 0.09% in the general population (adjusted hazard
ratio (aHR) = 12.97 (95% confidence interval (CI): 11.56-14.55)). Thirty-day
cumulative incidences of stroke were 2.16% for hip fracture patients and 0.21%
in the general population (aHR= 9.42 (95% CI: 8.71-10.19)). During the 31-
365 days following hip fracture, the aHR for MI was 1.05 (95% CI: 0.97-1.14)
and remained at this level during the remainder of follow-up (maximum of 20
years). The aHR for stroke was 1.29 (95% CI: 1.22-1.35) during the 31-365
days following hip fracture, remained elevated for up to 10 years, and then
decreased to the general-population level. During the first 30 days, up to 76%
of MI and stroke risk was attributable to interaction between hip fracture and
comorbidity.
Conclusions:
Patients with hip fracture are at increased risk of both MI and
stroke up to one year following the fracture. Risk of stroke, but not of MI, was
elevated during up to 10 years post-fracture. Although the absolute risks were
low, our finding underscores the importance of targeting multimorbidity, includ-
ing prevention and adequate treatment, to improve the prognosis of hip frac-
ture patients.
No conflicts of interest reported
13.